{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T18:02:01Z","timestamp":1780164121495,"version":"3.54.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["26JRRA731"],"award-info":[{"award-number":["26JRRA731"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11695-026-08629-x","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:20:17Z","timestamp":1775694017000},"page":"2025-2036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Preoperative GLP-1 Receptor Agonists Use and Perioperative Complications in Metabolic Bariatric Surgery: A Meta-Analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Chenglou","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"8629_CR1","unstructured":"1. ORGANIZATION W H. Obesity and overweight [Z]. 8 December 2025"},{"issue":"7","key":"8629_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1056\/NEJMoa1600869","volume":"376","author":"PR Schauer","year":"2017","unstructured":"Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes\u2009\u2212\u20095-Year Outcomes. N Engl J Med. 2017;376(7):641\u201351.","journal-title":"N Engl J Med"},{"key":"8629_CR3","doi-asserted-by":"crossref","unstructured":"3. COURCOULAS A P, YANOVSKI S Z, BONDS D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surg, 2014, 149(12):1323\u20139.","DOI":"10.1001\/jamasurg.2014.2440"},{"issue":"3","key":"8629_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/oby.23338","volume":"30","author":"I Uhe","year":"2022","unstructured":"Uhe I, Douissard J, Podetta M, et al. Roux-en-Y gastric bypass, sleeve gastrectomy, or one-anastomosis gastric bypass? A systematic review and meta-analysis of randomized-controlled trials. Obesity. 2022;30(3):614\u201327.","journal-title":"Obesity"},{"issue":"4","key":"8629_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018;27(4):740\u201356.","journal-title":"Cell Metab"},{"issue":"11","key":"8629_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989\u20131002.","journal-title":"N Engl J Med"},{"issue":"24","key":"8629_CR7","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221\u201332.","journal-title":"N Engl J Med"},{"key":"8629_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103408","volume":"87","author":"SK Kamarajah","year":"2025","unstructured":"Kamarajah SK, Gudiozzi N, Findlay JM, et al. Evaluation of safety of preoperative GLP-1 receptor agonists in patients undergoing elective surgery: a systematic review, meta-analysis and meta-regression. EClinicalMedicine. 2025;87:103408.","journal-title":"EClinicalMedicine"},{"issue":"9","key":"8629_CR9","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1007\/s11695-025-08137-4","volume":"35","author":"A Esparham","year":"2025","unstructured":"Esparham A, Sheikhbahaei E, Anari Moghadam H, et al. Preoperative Glucagon-Like Peptide-1 Receptor Agonists and Bariatric Surgery Outcomes: A Systematic Review. Obes Surg. 2025;35(9):3939\u201346.","journal-title":"Obes Surg"},{"key":"8629_CR10","doi-asserted-by":"crossref","unstructured":"10. TANG T, ABBOTT S, LE ROUX C W, et al. Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis. Diabetes Obes Metab, 2018, 20(3):745\u20138.","DOI":"10.1111\/dom.13131"},{"issue":"3","key":"8629_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.soard.2024.09.013","volume":"21","author":"X Shan","year":"2025","unstructured":"Shan X, Wang Y, Xiao X, et al. GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study. Surg Obes Relat Dis. 2025;21(3):247\u201355.","journal-title":"Surg Obes Relat Dis"},{"issue":"10","key":"8629_CR12","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1007\/s11695-025-08258-w","volume":"35","author":"G Luc","year":"2025","unstructured":"Luc G, Dedieu A, Canard G, et al. Exploratory Assessment of Preoperative GLP-1 Receptor Agonists Before Sleeve Gastrectomy: A Retrospective Matched Analysis. Obes Surg. 2025;35(10):4383\u201392.","journal-title":"Obes Surg"},{"key":"8629_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Mckenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"10","key":"8629_CR14","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"8629_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/emermed-2020-209567","volume":"37","author":"M Amir-Behghadami","year":"2020","unstructured":"Amir-Behghadami M, Janati A. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020;37(6):387.","journal-title":"Emerg Med J"},{"issue":"9","key":"8629_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"8629_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jclinepi.2021.09.021","volume":"141","author":"S Minozzi","year":"2022","unstructured":"Minozzi S, Dwan K, Borrelli F, et al. Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction. J Clin Epidemiol. 2022;141:99\u2013105.","journal-title":"J Clin Epidemiol"},{"key":"8629_CR18","doi-asserted-by":"crossref","unstructured":"18. HAKIM M, FATHI M, ABDULRAZIQ M, et al. Incidence of adhesions in patients using liraglutide before laparoscopic sleeve gastrectomy. Surg Endosc, 2022, 36(11):8503\u20138.","DOI":"10.1007\/s00464-022-09294-8"},{"issue":"5","key":"8629_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000531459","volume":"16","author":"G Martines","year":"2023","unstructured":"Martines G, Dezi A, Giove C, et al. Efficacy of Intragastric Balloon versus Liraglutide as Bridge to Surgery in Super-Obese Patients. Obes Facts. 2023;16(5):457\u201364.","journal-title":"Obesity Facts"},{"issue":"12","key":"8629_CR20","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","volume":"37","author":"M Ilanga","year":"2023","unstructured":"Ilanga M, Heard JC, Mcclintic J, et al. Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study. Surg Endosc. 2023;37(12):9509\u201313.","journal-title":"Surg Endosc"},{"issue":"12","key":"8629_CR21","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1007\/s00464-024-11231-w","volume":"38","author":"G Martines","year":"2024","unstructured":"Martines G, Giove C, Carlucci B, et al. Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy. Surg Endosc. 2024;38(12):7152\u20137.","journal-title":"Surg Endosc"},{"issue":"2","key":"8629_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11695-024-07651-1","volume":"35","author":"Q Abuhasan","year":"2025","unstructured":"Abuhasan Q, Funk LM, Holl JL, et al. Preoperative Glucagon-Like Peptide-1 Receptor Agonist Utilization and Association with Bariatric Surgery Outcomes. Obes Surg. 2025;35(2):556\u201360.","journal-title":"Obes Surg"},{"issue":"5","key":"8629_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamasurg.2025.0001","volume":"160","author":"V Mathur","year":"2025","unstructured":"Mathur V, Wasden K, Shin TH, et al. Neoadjuvant Semaglutide, Bariatric Surgery Weight Loss, and Overall Outcomes. JAMA Surg. 2025;160(5):594\u20136.","journal-title":"JAMA Surgery"},{"issue":"9","key":"8629_CR24","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s11695-025-08136-5","volume":"35","author":"A Poljo","year":"2025","unstructured":"Poljo A, Reichl JJ, B\u00fcRGI S, et al. Surgical Outcomes in Patients with Preoperative GLP-1 Therapy: A Retrospective Analysis. Obes Surg. 2025;35(9):3847\u201357.","journal-title":"Obes Surg"},{"issue":"7","key":"8629_CR25","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1007\/s00464-025-11838-7","volume":"39","author":"M Friesch","year":"2025","unstructured":"Friesch M, Fernando M, Sheedy E, et al. Effects of preoperative glucagon-like peptide-1 receptor agonist therapy on weight loss following bariatric surgery. Surg Endosc. 2025;39(7):4545\u201350.","journal-title":"Surg Endosc"},{"key":"8629_CR26","doi-asserted-by":"crossref","unstructured":"26. HUNG K C, CHANG L C, TAN P H, et al. Preoperative GLP-1 Receptor Agonists Exposure and Risk of Postoperative Acute Kidney Injury after Metabolic and Bariatric Surgery: A Retrospective Study. Obes Surg. 2025;36(2):418\u201328.","DOI":"10.1007\/s11695-025-08436-w"},{"issue":"4","key":"8629_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/acn3.52300","volume":"12","author":"AY Azzam","year":"2025","unstructured":"Azzam AY, Essibayi MA, Vaishnav D, et al. Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study. Ann Clin Transl Neurol . 2025;12(4):746\u201355.","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"8629_CR28","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S4283","volume":"2","author":"CW Chia","year":"2009","unstructured":"Chia CW, Egan JM. Role and development of GLP-1 receptor agonists in the management of diabetes. Diabetes Metab Syndr Obes. 2009;2:37.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"12","key":"8629_CR29","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1002\/oby.23905","volume":"31","author":"EW Flanagan","year":"2023","unstructured":"Flanagan EW, Spann R, Berry SE, et al. New insights in the mechanisms of weight-loss maintenance: Summary from a Pennington symposium. Obesity. 2023;31(12):2895\u2013908.","journal-title":"Obesity"},{"issue":"11","key":"8629_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029282","volume":"12","author":"ED Michos","year":"2023","unstructured":"Michos ED, Lopez-Jimenez F, Gulati M. Role of Glucagon-Like Peptide-1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity. J Am Heart Assoc. 2023;12(11):e029282.","journal-title":"Journal of the American Heart Association"},{"issue":"2","key":"8629_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/jc.2017-02006","volume":"103","author":"MA Halim","year":"2018","unstructured":"Halim MA, Degerblad M, Sundbom M, et al. Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans. J Clin Endocrinol Metab. 2018;103(2):575\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"8629_CR32","volume":"17","author":"N Nagib","year":"2025","unstructured":"Nagib N, Avila D, Partyka J, et al. Weighing the Risks: Small Bowel Obstruction Associated With Semaglutide Use in the Postoperative Abdomen. Cureus. 2025;17(7):e88589.","journal-title":"Cureus"},{"issue":"7","key":"8629_CR33","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.2337\/dc12-2713","volume":"36","author":"PC Butler","year":"2013","unstructured":"Butler PC, Elashoff M, Elashoff R, et al. A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe? Diabetes Care. 2013;36(7):2118\u201325.","journal-title":"Diabetes Care"},{"issue":"4","key":"8629_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4158\/EP11290.OR","volume":"18","author":"HM Lando","year":"2012","unstructured":"Lando HM, Alattar M, Dua AP. Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting. Endocr Pract. 2012;18(4):472\u20137.","journal-title":"Endocr Pract"},{"key":"8629_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1043789","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Chen J, Wang L, et al. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database. Front Endocrinol (Lausanne). 2022;13:1043789.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8629_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6820377","volume":"2022","author":"D Xu","year":"2022","unstructured":"Xu D, Nair A, Sigston C, et al. Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations. Cardiovasc Ther. 2022;2022:6820377.","journal-title":"Cardiovasc Ther"},{"issue":"8","key":"8629_CR37","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1007\/s00125-025-06448-w","volume":"68","author":"M Heni","year":"2025","unstructured":"Heni M, FR\u00fcHWALD L, Karges W, et al. Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study. Diabetologia. 2025;68(8):1666\u201373.","journal-title":"Diabetologia"},{"key":"8629_CR38","doi-asserted-by":"crossref","unstructured":"38. PAPAMARGARITIS D, LE ROUX C W, HOLST J J, et al. New therapies for obesity. Cardiovasc Res, 2024, 119(18): 2825\u201342.","DOI":"10.1093\/cvr\/cvac176"},{"issue":"7","key":"8629_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236133","volume":"15","author":"R Arakawa","year":"2020","unstructured":"Arakawa R, Febres G, Cheng B, et al. Prospective study of gut hormone and metabolic changes after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. PLoS One. 2020;15(7):e0236133.","journal-title":"PLoS One"},{"key":"8629_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00092","volume":"9","author":"KM Heppner","year":"2015","unstructured":"Heppner KM, Perez-Tilve D. GLP-1 based therapeutics: simultaneously combating T2DM and obesity. Front Neurosci. 2015;9:92.","journal-title":"Front Neurosci"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08629-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08629-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08629-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:58:18Z","timestamp":1780163898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08629-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8629"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08629-x","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article does not require informed consent because the study data were downloaded from the open database. This is a secondary analysis of data from previous studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Informed Consent"}},{"value":"Not applicable. This article did not require an ethical board approval because the study data were downloaded from the open database. This is a secondary analysis of data from previous studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}